logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Yeo, Marcus, Dr
    Born in July 1972
    Individual (8 offsprings)
    Officer
    2011-06-07 ~ now
    OF - Director → CIF 0
    Mr Marcus Yeo
    Born in July 1972
    Individual (8 offsprings)
    Person with significant control
    2017-06-07 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

SUMMIT BIOTECHNOLOGY LTD

Period: 2011-06-07 ~ now
Company number: 07660899
Registered name
SUMMIT BIOTECHNOLOGY LTD - now
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
1,194 GBP2025-06-30
465 GBP2024-06-30
Debtors
13,055 GBP2025-06-30
4,000 GBP2024-06-30
Cash at bank and in hand
625 GBP2025-06-30
27,873 GBP2024-06-30
Current Assets
13,680 GBP2025-06-30
31,873 GBP2024-06-30
Net Current Assets/Liabilities
-1,084 GBP2025-06-30
18,433 GBP2024-06-30
Total Assets Less Current Liabilities
110 GBP2025-06-30
18,898 GBP2024-06-30
Equity
Called up share capital
100 GBP2025-06-30
100 GBP2024-06-30
Retained earnings (accumulated losses)
10 GBP2025-06-30
18,798 GBP2024-06-30
Equity
110 GBP2025-06-30
18,898 GBP2024-06-30
Average Number of Employees
12024-07-01 ~ 2025-06-30
12023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Gross Cost
Other
2,639 GBP2025-06-30
1,490 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
1,445 GBP2025-06-30
1,025 GBP2024-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
420 GBP2024-07-01 ~ 2025-06-30
Property, Plant & Equipment
Other
1,194 GBP2025-06-30
465 GBP2024-06-30
Trade Debtors/Trade Receivables
Current
7,560 GBP2025-06-30
4,000 GBP2024-06-30
Other Debtors
Amounts falling due within one year
5,495 GBP2025-06-30
0 GBP2024-06-30
Debtors
Current, Amounts falling due within one year
13,055 GBP2025-06-30
Amounts falling due within one year, Current
4,000 GBP2024-06-30
Corporation Tax Payable
Current
14,104 GBP2025-06-30
12,702 GBP2024-06-30
Other Creditors
Current
660 GBP2025-06-30
738 GBP2024-06-30
Creditors
Current
14,764 GBP2025-06-30
13,440 GBP2024-06-30

  • SUMMIT BIOTECHNOLOGY LTD
    Info
    Registered number 07660899
    82b High Street, Sawston, Cambridge CB22 3HJ
    PRIVATE LIMITED COMPANY incorporated on 2011-06-07 (14 years 11 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-12-07
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.